BETA: Please send your feedback!

Medicines

NAS:MDCO

Pharmaceuticals: Other

$1.80bn
MID cap
$24.34 (1.84%)
31.0716%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on leading acute and intensive care hospitals worldwide. The company markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
website

Headquarters

8 Sylvan Way
Parsippany, NJ 07054-3801

Executives

Name Title Gender
Loretta M. Itri, MD EVP-Global Health Science & Regulatory Affairs Female
Tony Kingsley, MBA President & Chief Operating Officer Male
Bill O'Connor, CPA SVP, Chief Financial & Accounting Officer Male
Fred Eshelman, PhD Non-Executive Chairman Male
Clive A. Meanwell, MD, PhD Chief Executive Officer & Director Male
John W. Villiger, PhD Executive Vice President Male
T. Scott Johnson, MD Founder Male
Helmut Giersiefen, PhD Founder Male
Krishna Gorti, MD Vice President-Investor Relations Male
David Kallend, Phd Vice President & Global Medical Director Male
Stephen M. Rodin Secretary, Senior Vice President & General Counsel Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

Medicines - Competitors and Related Companies

How Medicines stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.

Medicines

NAS:MDCO

Pharmaceuticals: Other

$1.80bn
MID cap
$24.34 (1.84%)
31.0716%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…